Background: Ischemia modified albumin, IMA is albumin which has altered in its amino terminal due to ischemia, following which, it loses its capacity to bind to metal cations like cobalt ions. It is also a candidate marker of oxidative stress. Normal pregnancy is associated with production of free radicals compared to non-pregnant women.
Materials and methods: In this prospective study, the IMA and IMA albumin ratio levels of 40 pregnant women with pregnancy induced hypertension of age group 18–40 years were compared with the 40 age matched healthy pregnant controls. The albumin cobalt-binding test was used to estimate the IMA levels and serum albumin levels were estimated using absorbance by Bromocresol green.
Results: Mean levels of IMA were higher in the case group as compared to control group (0.52 ±0.1 ABSU vs 0.04 ± 0.03 ABSU, p <0.05). The albumin levels were lower in the patients’ group compared to the controls’ group and the difference was statistically significant (p <0.05). The ratio of IMA to normal serum albumin (IMAR) was higher in the patients’ group than the controls group (p <0.05).
Conclusion: Ischemia modified albumin and the ratio of IMA to normal serum albumin are significantly elevated in hypertensive disorders of pregnancy as compared to normal healthy pregnant controls and therefore are useful biomarkers of pregnancy induced hypertension.
Bahinipati JT, Mohapatra CP, Pradhan T. Role of maternal serumischemia modified albumin as a biochemical marker inpreeclampsia. Biomed Res-India 2014;25:11-14.
Wu AH. The ischemia-modified albumin biomarker for myocardialischemia.MLO Med Lab Obs 2003;35(6):36-8,40.
Gustafsson JE. Improved specificity of serum albumin determination and estimation of “acute phase reactants” by use ofthe bromocresol green reaction. Clinical Chemistry 1976;22(5):616-22.
Ueno T, Hirayama S, Ito M, Nishioka E, Fukushima Y, Satoh T et al. Albumin concentration determined by the modified bromocresol purple method is superior to that by the bromocresol green method for assessing nutritional status in malnourished patients with inflammation. Ann ClinBiochem 2013;50(6):576-84.
van Rijn BB, Franx A, Sikkema JM, van Rijn HJM, Bruinse HW, Voorbij HAM. Ischemia Modified Albumin in Normal Pregnancy and Preeclampsia. Hypertension in pregnancy 2008;27:159-67.
Dayanand CD, Bambrana V, Sivaraj N, Inala MSR. Is ischemia Modified Albumin a Marker in Preeclampsia? A Case Control Study in Kolar Population-a South West of India. Am. J. Pharm Health Res 2015;3(6):84-90.
Vyakaranam S, Bhongir AV, Patlolla D, Chintapally R. Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study. Int J Reprod Contracept Obstet Gynecol. 2015;4:611-6.
D’souza JM, Pai VR, Harish S, Shriyan C, D’souza N. IMA and IMAR in serum and saliva of preeclampsia - a preliminary study. Hypertens Pregnancy. 2014;33(4):440-8
Chamy VM, Lepe J, Catalán A, Retamal D, Escobar JA, Madrid EM. Oxidative stress is closely related to clinical severity of preeclampsia. Biol Res 2006;39(2):229-36.